This was largely due to the pairing of artemisinin derivatives with older drugs that had existing resistance problems. But some experts think the emergence of partial resistance to artemisinin ...

The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in ...